These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 19111842)
1. Quality control of human ABCG2 protein in the endoplasmic reticulum: ubiquitination and proteasomal degradation. Wakabayashi-Nakao K; Tamura A; Furukawa T; Nakagawa H; Ishikawa T Adv Drug Deliv Rev; 2009 Jan; 61(1):66-72. PubMed ID: 19111842 [TBL] [Abstract][Full Text] [Related]
2. Disruption of N-linked glycosylation enhances ubiquitin-mediated proteasomal degradation of the human ATP-binding cassette transporter ABCG2. Nakagawa H; Wakabayashi-Nakao K; Tamura A; Toyoda Y; Koshiba S; Ishikawa T FEBS J; 2009 Dec; 276(24):7237-52. PubMed ID: 19909340 [TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2. Nakagawa H; Tamura A; Wakabayashi K; Hoshijima K; Komada M; Yoshida T; Kometani S; Matsubara T; Mikuriya K; Ishikawa T Biochem J; 2008 May; 411(3):623-31. PubMed ID: 18237272 [TBL] [Abstract][Full Text] [Related]
4. Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations. Furukawa T; Wakabayashi K; Tamura A; Nakagawa H; Morishima Y; Osawa Y; Ishikawa T Pharm Res; 2009 Feb; 26(2):469-79. PubMed ID: 18958403 [TBL] [Abstract][Full Text] [Related]
5. [Genetic polymorphisms of human ABC transporter ABCG2: Porphyria risk and ER quality control]. Wakabayashi K; Tamura A; Ishikawa T Seikagaku; 2007 Feb; 79(2):151-7. PubMed ID: 17370621 [No Abstract] [Full Text] [Related]
6. Intramolecular disulfide bond is a critical check point determining degradative fates of ATP-binding cassette (ABC) transporter ABCG2 protein. Wakabayashi K; Nakagawa H; Tamura A; Koshiba S; Hoshijima K; Komada M; Ishikawa T J Biol Chem; 2007 Sep; 282(38):27841-6. PubMed ID: 17686774 [TBL] [Abstract][Full Text] [Related]
7. Human ABC transporters ABCG2 (BCRP) and ABCG4. Koshiba S; An R; Saito H; Wakabayashi K; Tamura A; Ishikawa T Xenobiotica; 2008 Jul; 38(7-8):863-88. PubMed ID: 18668433 [TBL] [Abstract][Full Text] [Related]
8. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2. Ripperger A; Benndorf RA Biochem Pharmacol; 2016 Mar; 104():139-47. PubMed ID: 26903388 [TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-mediated proteasomal degradation of ABC transporters: a new aspect of genetic polymorphisms and clinical impacts. Nakagawa H; Toyoda Y; Wakabayashi-Nakao K; Tamaki H; Osumi M; Ishikawa T J Pharm Sci; 2011 Sep; 100(9):3602-19. PubMed ID: 21567408 [TBL] [Abstract][Full Text] [Related]
10. Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2. Henriksen U; Gether U; Litman T J Cell Sci; 2005 Apr; 118(Pt 7):1417-26. PubMed ID: 15769853 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of productive folding and endoplasmic reticulum-associated degradation of glycoproteins and non-glycoproteins. Ninagawa S; George G; Mori K Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129812. PubMed ID: 33316349 [TBL] [Abstract][Full Text] [Related]
12. ABCG2 -- a transporter for all seasons. Sarkadi B; Ozvegy-Laczka C; Német K; Váradi A FEBS Lett; 2004 Jun; 567(1):116-20. PubMed ID: 15165903 [TBL] [Abstract][Full Text] [Related]
13. Methods to examine the impact of nonsynonymous SNPs on protein degradation and function of human ABC transporter. Ishikawa T; Wakabayashi-Nakao K; Nakagawa H Methods Mol Biol; 2013; 1015():225-50. PubMed ID: 23824860 [TBL] [Abstract][Full Text] [Related]
14. Human ABC transporter ABCG2 in xenobiotic protection and redox biology. Wakabayashi K; Tamura A; Saito H; Onishi Y; Ishikawa T Drug Metab Rev; 2006; 38(3):371-91. PubMed ID: 16877258 [TBL] [Abstract][Full Text] [Related]
15. Posttranslational negative regulation of glycosylated and non-glycosylated BCRP expression by Derlin-1. Sugiyama T; Shuto T; Suzuki S; Sato T; Koga T; Suico MA; Kusuhara H; Sugiyama Y; Cyr DM; Kai H Biochem Biophys Res Commun; 2011 Jan; 404(3):853-8. PubMed ID: 21184741 [TBL] [Abstract][Full Text] [Related]
16. The role of human ABC transporter ABCG2 (BCRP) in pharmacotherapy. Ishikawa T Adv Drug Deliv Rev; 2009 Jan; 61(1):1-2. PubMed ID: 19124052 [No Abstract] [Full Text] [Related]
17. Breast cancer resistance protein (BCRP/ABCG2). Staud F; Pavek P Int J Biochem Cell Biol; 2005 Apr; 37(4):720-5. PubMed ID: 15694832 [TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum degradation of a mutated ATP-binding cassette transporter Pdr5 proceeds in a concerted action of Sec61 and the proteasome. Plemper RK; Egner R; Kuchler K; Wolf DH J Biol Chem; 1998 Dec; 273(49):32848-56. PubMed ID: 9830032 [TBL] [Abstract][Full Text] [Related]
19. Single-nucleotide polymorphisms in a short basic motif in the ABC transporter ABCG2 disable its trafficking out of endoplasmic reticulum and reduce cell resistance to anticancer drugs. Zhang W; Yang Y; Dong Z; Shi Z; Zhang JT J Biol Chem; 2019 Dec; 294(52):20222-20232. PubMed ID: 31719146 [TBL] [Abstract][Full Text] [Related]
20. ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases. Fischer S; Lakatos PL; ; Lakatos L; Kovacs A; Molnar T; Altorjay I; Papp M; Szilvasi A; Tulassay Z; Osztovits J; Papp J; Demeter P; Schwab R; Tordai A; Andrikovics H Scand J Gastroenterol; 2007 Jun; 42(6):726-33. PubMed ID: 17505995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]